Skip to main content

Table 1 Demographics, hemodynamic and CTPA data

From: Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension

 

IPAH

Sch-PAH

p

Gender

   

 Male

4 (16 %)

4 (18 %)

ns

 Female

21 (84 %)

18 (81 %)

 

Age

40 ± 13

48 ± 13

0.019

Functional class

   

 I/II

7 (28 %)

7 (32 %)

ns

 III/IV

18 (72 %)

15 (68 %)

 

Hemodynamics

   

 mPAP (mmHg)

63 ± 23

56 ± 23

ns

 RAP (mmHg)

15 ± 11

9 ± 4

0.018

 PAOP (mmHg)

12 ± 6

15 ± 7

ns

 PVR (IU)

15.4 ± 5.1

10.2 ± 6.1

0.009

 CO (mL/min)

4.9 ± 1.8

3.8 ± 1.2

0.03

CTPA measurements

   

MPAD, cm

3.7 ± 1.1

4.5 ± 1.8

0.018

 RPAD, cm

2.58 ± 0.47

3.16 ± 0.91

0.009

 LPAD, cm

2.5 ± 0.4

2.7 ± 0.6

ns

  1. IPAH idiopathic pulmonary arterial hypertension, Sch-PAH schistosomiasis associated pulmonary hypertension, NYHA FC New York Heart Association functional class, mPAP mean pulmonary arterial pressure, RAP right atrial pressure, PAOP pulmonary artery occlusion pressure, PVR pulmonary vascular resistance, CO cardiac output, MPAD main pulmonary artery diameter, RPAD right pulmonary artery diameter, LPAD left pulmonary artery diameter, ns non significant